Drug
Oxcarbazepine
Oxcarbazepine: highest development phase Approved, developed by Supernus Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Supernus Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| OXTELLAR XR | Approved | |
| Oxcarbazepine XR NCT00908349 | Phase 3 | Partial Epilepsy |
Latest
No recent events.
Follow Oxcarbazepine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.